NewMed Energy - Limited Partnership (DKDRF) Stock
NewMed Energy - Limited Partnership, headquartered in Herzliya, Israel, is an energy company primarily involved in the upstream oil and gas sector. Its operations encompass the exploration, development, extraction, and marketing of crude oil, natural gas, and condensate across Israel and Cyprus.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About NewMed Energy - Limited Partnership
NewMed Energy - Limited Partnership, headquartered in Herzliya, Israel, is an energy company primarily involved in the upstream oil and gas sector. Its operations encompass the exploration, development, extraction, and marketing of crude oil, natural gas, and condensate across Israel and Cyprus. The partnership possesses significant interests in several key energy projects. These include the substantial Leviathan project, spanning 500 km² off the coast of Haifa, and the Yam Tethys project, also covering 500 km² situated west of Ashkelon. In Cyprus, it holds a stake in Block 12, an area approximately 386 km² in size. Additionally, its Israeli portfolio features the New Ofek license (around 344 km²) and the New Yahel license (397.5 km²), alongside the Tanin and Karish leases, which together cover about 500 km² west of Nahariya. NewMed Energy serves a diverse clientele, including independent power producers and various industrial companies. The general partner overseeing its operations is NewMed Energy Management Ltd. Originally established in 1993, the entity was formerly known as Delek Drilling - Limited Partnership before adopting its current name in February 2022. It functions as a subsidiary of Delek Energy Systems Ltd.
NewMed Energy - Limited Partnership is headquartered in IL.
NewMed Energy - Limited Partnership (DKDRF) stock trades at $5.10 with a market capitalization of $5.99B. The stock is valued at a price-to-earnings (P/E) ratio of 28.45, price-to-book of 3.55, price-to-sales of 7.55. Over the past 52 weeks the stock has ranged between $4.45 and $7.32, and currently trades 30.3% below its 52-week high. It pays a dividend yielding 3.92%.
On profitability, NewMed Energy - Limited Partnership generates a return on equity (ROE) of 12.09%, above the typical market average, return on capital employed of 8.98%, an operating margin of 40.22%, a net profit margin of 26.49%.
Official website: www.newmedenergy.com